A Clinical Observation on Qi-Supplementing Blood-Quickening Femur-Nourishing Decoction Combined with Interventional Therapy for 40 Cases of Avascular Necrosis

PENG Zhi

doi:10.13288/j.11-2166/r.2013.16.030

您当前的位置：

首页 >

文章列表页 >

A Clinical Observation on Qi-Supplementing Blood-Quickening Femur-Nourishing Decoction Combined with Interventional Therapy for 40 Cases of Avascular Necrosis

更新时间：2021-11-17

- A Clinical Observation on Qi-Supplementing Blood-Quickening Femur-Nourishing Decoction Combined with Interventional Therapy for 40 Cases of Avascular Necrosis
- Journal of Traditional Chinese Medicine Vol. 54, Issue 16, Pages: 1390-1393(2013)
- 作者机构：
  
  贵州省人民医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2013.16.030
  CLC： R681.8
- Published：2013
- 稿件说明：
移动端阅览
[1]彭智.补气活血养股汤结合介入疗法治疗无菌性股骨头坏死症40例临床观察[J].中医杂志,2013,54(16):1390-1393.

PENG Zhi. A Clinical Observation on Qi-Supplementing Blood-Quickening Femur-Nourishing Decoction Combined with Interventional Therapy for 40 Cases of Avascular Necrosis[J]. Journal of Traditional Chinese Medicine2013, 54(16): 1390-1393.
[1]彭智.补气活血养股汤结合介入疗法治疗无菌性股骨头坏死症40例临床观察[J].中医杂志,2013,54(16):1390-1393. DOI： 10.13288/j.11-2166/r.2013.16.030.

PENG Zhi. A Clinical Observation on Qi-Supplementing Blood-Quickening Femur-Nourishing Decoction Combined with Interventional Therapy for 40 Cases of Avascular Necrosis[J]. Journal of Traditional Chinese Medicine2013, 54(16): 1390-1393. DOI： 10.13288/j.11-2166/r.2013.16.030.

摘要

目的观察补气活血养股汤结合介入疗法治疗早中期无菌性股骨头坏死症（ATBD）气虚血瘀兼肝肾亏虚证的临床疗效及安全性。方法 80例ATBD气虚血瘀兼肝肾亏虚证患者随机分为治疗组（给予介入疗法及中药补气活血养股汤）和对照组（仅给予介入疗法）各40例

观察两组患者中医及西医的临床疗效

治疗前后进行Harris评分及中医症状评分

并观察不良反应。结果治疗组西医疗效总有效率为82.50%

对照组为70.00%

治疗组优于对照组（P<0.05）。治疗组中医疗效总有效率85.00%

对照组为65.00%

治疗组优于对照组（P<0.05）。两组治疗后Harris评分比较

治疗组各项评分及总分均较对照组明显提高（P<0.05）。治疗后治疗组中医症状评分各项评分及总分均较对照组降低明显（P<0.05或P<0.01）。两组患者不良反应及手术并发症比较差异无统计学意义（P>0.05）。结论补气活血养股汤结合介入疗法治疗早中期ATBD气虚血瘀兼肝肾亏虚证疗效肯定

能明显改善临床症状

且不良反应少。

Abstract

Objective To observe the efficacy and safety of Qi-Supplementing Blood-Quickening Femur-Nourishing Decoction（QSBQFND） combined with interventional therapy for early-middle stage avascular necrosis（AVN）.Methods Eighty early-middle stage AVN patients with qi deficiency blood stasis and liver-kidney deficiency pattern were randomized into the treatment group and control group

with 40 in each.The treatment group was given QSBQFND and interventional therapy.The control group was given interventional therapy.The efficacy of TCM and western medicine

Harris Hip Score（HHS）

TCM symptom scores and adverse reactions were observed.Results The efficacy of western medicine in the treatment group and control group was 82.50% and 70.00% respectively

with a significant difference between groups（P<0.05）.The efficacy of TCM in the treatment group and control group was 85.00% and 65.00% respectively

with a significant difference between groups（P<0.05）.Comparing with the control group

the scores of HHS in the treatment group were significantly increased（P<0.05）.Comparing with the control group

the TCM symptom scores in the treatment group were significantly decreased（P<0.05 or P<0.01）.There was no significant difference between groups in the adverse reactions and surgical complications（P>0.05）.Conclusion QSBQFND combined with interventional therapy is effective for early-middle stage AVN and it can obviously relieve the symptoms.

关键词

Keywords

references

查看原文

Views

158

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Compound Tongluo Decoction（复方通络饮）in Treating Subcortical Ischemic Vascular Mild Cognitive Impairment with Liver-Kidney Deficiency and Phlegm-Stasis Obstructing Collateral Syndrome： A Randomized Controlled Trial

Clinical Observation on 2170 Cases of Cervical Spondylosis of Nerve Root and Vertebral Artery Type Treated with Shujin Tongluo Granule（舒筋通络颗粒）

Theoretical Foundation and Practice of Qi and Blood Interacting in Vessels

Retrospective Analysis on Characteristics of Syndrome and Pathogenesis of Diabetic Kidney Disease

Difference of Biological Markers Expression between Myocardial Infarction Model Rats with Qi Stagnation and Blood Stasis Type and Qi Deficiency and Blood Stasis Type

Related Author

HUI Zhen

WANG Jingqing

FU Jiarong

DAI Longhua

ZHOU Ziqin

LIANG De

CUI Jianchao

ZHANG Huajian

Related Institution

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine

Danyang Hospital of Traditional Chinese Medicine

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Shineway Pharmaceutical Group Ltd.

Engineering and Technological Research Center for Chinese Medical Injection

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰